New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
November 17, 2022 - Fresenius launched an authorized brand alternative (ABA) of Acrotech Biopharma’s Folotyn (pralatrexate) injection.
Download PDF
Return to publications
